ask="N/A"
ask_size="N/A"
average_daily_volume="53843"
bid="4.550"
bid_size="1000"
book_value="2.777"
change="+0.225"
change_from_200_day_moving_average="-0.507"
change_from_50_day_moving_average="0.446"
change_from_52_week_high="-4.125"
change_From_52_week_low="1.022"
change_in_percent="+5.172%"
close="4.575"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.646"
ebitda="-37.76M"
eps_estimate_current_year="-2.000"
eps_estimate_next_quarter="-0.530"
eps_estimate_next_year="-2.110"
ex_dividend_date="N/A"
float_shares="12976000"
high="4.925"
high_52_weeks="8.700"
last_trade_date="3/7/2017"
last_trade_price="4.575"
last_trade_size="167"
last_trade_time="3:59pm"
low="4.400"
low_52_weeks="3.553"
market_capitalization="106.81M"
moving_average_200_day="5.082"
moving_average_50_day="4.129"
name="ProQR Therapeutics N.V."
notes="N/A"
one_year_target_price="8.960"
open="4.400"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-9.985%"
percent_change_from_50_day_moving_average="+10.813%"
percent_change_from_52_week_high="-47.414%"
percent_change_from_52_week_low="+28.768%"
previous_close="4.350"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.566"
price_per_sales="36.510"
revenue="2.78M"
shares_outstanding="23346000"
short_ratio="4.730"
stock_exchange="NGM"
symbol="PRQR"
volume="218554"
weeks_range_52="3.553 - 8.700"
